Tenderwize
Wróć do wyszukiwania

Open-house contract for Aclidiniumbromid/Formoterol

Techniker Krankenkasse·Hamburg, Germany·Deadline Aug 29, 2026 · 4 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-06 - Aclidiniumbromid/Formoterol (Wirkstoffkombination)

45/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

45 / 100

Złożoność

58 / 100

Czynniki ryzyka

The notice says offers/contracts cannot be submitted through the portal and must be sent by email with qualified electr...

Only pharmaceutical undertakings meeting the AMG-based eligibility conditions and exclusion declarations may participat...

Submission deadline in 4 days

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2026
  • Conclude rebate contracts under § 130c SGB V for the product combination Aclidiniumbromid/Formoterol.
  • Provide supplies of the relevant pharmaceutical products under an open-house model.
Pokaż pełne podsumowanie

Open-house supply arrangement in Germany for the pharmaceutical product combination Aclidiniumbromid/Formoterol, led by Techniker Krankenkasse. The notice states that contracts may be concluded with all suitable pharmaceutical companies under uniform conditions, without individual negotiations or exclusivity. Electronic submission via the portal is not allowed; contracts must be submitted by email with qualified electronic signature or by post, and the participation documents are only available to companies that market or credibly intend to market the relevant product. No contract value is stated.

Ryzyka

The notice says offers/contracts cannot be submitted through the portal and must be sent by email with qualified electr...

Only pharmaceutical undertakings meeting the AMG-based eligibility conditions and exclusion declarations may participat...

Submission deadline in 4 days

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Applicant must be a pharmaceutical undertaking in the sense of § 4(18) AMG for the offered medicinal products.
  • Applicant must have its seat in the AMG territory, another EU Member State, or another EEA State.
  • Applicant must have a valid marketing authorisation for the relevant medicinal product(s), or otherwise be entitled to place them on the market in its own name.

Kryteria udzielenia

Lot 1

Other / no substantive weighted award criterion stated

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Open-house contract for Aclidiniumbromid/Formoterol

Supply lot for the medicinal product combination Aclidiniumbromid/Formoterol under an open-house rebate contract. The contract is open to all eligible pharmaceutical companies, with no exclusivity and no individual negotiation. Lot information comes from structured data and the notice text.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

Germany

Czas trwania

Aug 2024 - Aug 2026

Kategoria

Pharmaceutical products

Kryteria udzielenia

Other / no substantive weighted award criterion stated

Termin

Deadline Aug 29, 2026

Szczegóły zamówienia

Data publikacji
15 Jul 2024
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
422415-2024

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3